Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study)

NAActive, not recruitingINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

August 5, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Myocardial InjuryMyocarditisCOVID-19 VaccinationSARS-CoV-2Cardiac MRI
Interventions
DIAGNOSTIC_TEST

Cardiac PET/MRI

An imaging technique that combines the strengths of both MRI and PET into one comprehensive study. This technique allows for detailed myocardial tissue characterization with MRI (including assessment of myocardial edema and fibrosis) and metabolic changes (including myocardial inflammation).

DIAGNOSTIC_TEST

Blood Biomarkers

Markers of cardiac damage, inflammation, circulating microRNA profiles, and COVID antibody levels will be evaluated in patients after COVID-19 vaccination.

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER